FDA Inspection 1223760 — Fougera Pharmaceuticals, LLC.

Fougera Pharmaceuticals, LLC. — FEI 2410271

The FDA completed an inspection of Fougera Pharmaceuticals, LLC. on Nov 17, 2023 in Hicksville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 17, 2023
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hicksville, NY (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.